Dr. Jamshed Haq

Email: jhaq@labpath.com

Address: 315 Erin Drive Knoxville, Tennessee 37919

Education

King Edward Medical College
M.D. College of Medicine
Lahore, Pakistan

Residencies

Anatomic Pathology
Petersburg General Hospital, neuropathology rotation
Medical College of Virginia
Richmond, Virginia
1965-1967

Henry Ford Hospital
Detroit, Michigan
1967-1969

Chief Resident, Pathology
McMaster University
Hamilton, Ontario
Canada
July to October, 1986

Internal Medicine
Petersburg General Hospital, Petersburg, VA
Thoracic Surgery, Mayo Hospital, Lahore, Pakistan
Internal Medicine, Services Hospital, Lahore, Pakistan

Board Certification
Anatomic and Clinical Pathology, The American Board of Pathology
General Pathology, Royal College of Physicians and Surgeons of Canada

Medical Licensure

Tennessee
Kentucky
Massachusetts (inactive)
Maine (inactive)
Medical Council of Canada for practice of general medicine in Canada

Society Memberships

Fellow, College of American Pathologists
Fellow, American Society of Clinical Pathologists
Fellow, Royal College of Physicians and Surgeons of Canada

Professional Experience

Associate Pathologists, Port Arthur General Hospital
Thunderbay, Ontario
1970-1972

Pathologist,Worcester Hahnemann Hospital
Worcester, Massachusetts
1972-1973

Associate Pathologist, Morristown Hamblen and Doctors Hospitals
Morristown, Tennessee
1974-1977

Pathologist, Knoxville Associated Pathologists
East Tennessee Baptist Hospital
1977-2008

Medical Director of Laboratory
Claiborne County Hospital
Tazewell, Tennessee 2008

Medical Director of Laboratory
Jellico Community Hospital
Jellico, Tennessee 2008

OUR LAB
Nashville, Tennessee
2008-2009

 

News and Events

Cancer survivors may be at higher risk of developing Melanoma. Read report

FDA approves Erivedge, the first drug to treat advanced basal cell carcinoma. Story

Diagnostic Update

KDL now providing FDA-approved BRAF testing for all mestastic melanomas. More

Contact Us

800.772.0951
865.584.1933
clientservices@kdlpathology.com
facebook icon

Stay Connected

Receive the DermPath Update or hear the latest news from KDL Pathology.